Raffles Medical Group Ltd
RAFLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $2 | $2 | $2 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 6.1% | -14% | 13.7% | – |
| Gross Profit | $0 | $0 | $1 | $1 |
| % Margin | 64.7% | 44.6% | 77.8% | 80.2% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 18.1% | 18.8% | 28.7% | 22.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 8.3% | 12.7% | 17.4% | 11.6% |
| EPS Diluted | 0.033 | 0.048 | 0.077 | 0.045 |
| % Growth | -30.7% | -37.3% | 71.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |